this post was submitted on 15 Apr 2025
9 points (100.0% liked)

Medicine Canada

224 readers
12 users here now

A community for Canadian physicians and medical professionals


๐Ÿ While this community is intended for Canadian discussions, you are free to post about other medical systems. We're all in this together :)



Related Communities

For better links and descriptions, see the pinned post in the Medical Community Hub ([email protected])


Rules

  1. No requests for professional advice or general medical information. Please do not solicit medical advice or share personal health anecdotes about yourself or others.

  2. No promotions, advertisements, surveys, or petitions.

  3. Link to high-quality, original research whenever possible: Posts which rely on or reference scientific data (e.g. an announcement about a medical breakthrough) should link to the original research in peer-reviewed medical journals or respectable news sources as judged by the moderators. Sensationalized titles, misrepresentation of results, or promotion of blatantly bad science may lead to removal.

  4. Act professionally and decently: /r/medicine is a public forum that represents the medical community and comments should reflect this. Please keep disagreement civil and focused on issues.

  5. Protect patient confidentiality. Please anonymize cases and remove any patient-identifiable information.

  6. No memes or low-effort posts: Memes, image links (including social media screenshots), images of text, or other low-effort posts or comments are not allowed.

These rules have been modelled after /r/medicine. While some rules were modified or skipped as this is a much smaller community, we can revisit the rules as we go. Thank you :)

founded 2 years ago
MODERATORS
 

New medical guideline features 10 recommendations, including one in favour of GLP-1 receptor agonists, the class of drugs that contains semaglutide, better known as the Type 2 diabetes medication Ozempic. Boxes of Ozempic and Wegovy are seen at a pharmacy in London, England, on March 8, 2024.

Doctors caring for young people with obesity should provide nutritionaland exercise advice, but should also consider offering weight-loss drugs and bariatric surgery to teenagers, according to the first new Canadian guideline on the treatment of pediatric obesity in nearly 20 years.

The clinical practice guideline, which provides advice to doctors on how to treat children with obesity, was published Monday in the Canadian Medical Association Journal. It features 10 recommendations, including one in favour of GLP-1 receptor agonists, the class of drugs that contains semaglutide, better known as the Type 2 diabetes medication Ozempic.


From The Globe and Mail via this RSS feed

top 1 comments
sorted by: hot top controversial new old
[โ€“] [email protected] 3 points 22 hours ago

The article is behind a paywall, but I assume they're talking about this https://www.cmaj.ca/content/197/14/E372

From table 1

1.2 Nutrition interventions

We suggest using nutritional interventions for managing obesity in children aged 18 years and younger.

Rationale: For critically important outcomes, no data were available, but for our very important outcome (BMIz), compared with minimal interventions, nutrition interventions had a small beneficial effect. No serious AEs were reported in any nutrition intervention studies. When mild to moderate AEs were reported, they were trivial. This recommendation relates to nutrition interventions exclusively, not in conjunction with other interventions.

This really should be the main focus of their guidance, not a sidenote.... Sugar and carbs are making these kids sick